Physician profile
Heidy Dorta
NPI 1225797715
$2,038.97
in general payments reported to CMS, 2019-2025
20 companies · $68.50 in 2025
The $68.50 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $537 · 2023: $1,234 · 2024: $200 · 2025: $68.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,426 · Education: $76.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,426.39 |
| Education | $76.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $411.45 | 2022-2023 | Xifaxan, Trulance |
| Abbvie INC. | $359.09 | 2022-2024 | |
| Janssen Biotech, INC. | $226.67 | 2022-2023 | Stelara |
| Ardelyx, INC. | $209.72 | 2022-2023 | Ibsrela |
| Intercept Pharmaceuticals, INC. | $163.69 | 2022-2023 | Ocaliva |
| Ironwood Pharmaceuticals, INC | $138.20 | 2022-2024 | Linzess |
| Redhill Biopharma INC. | $96.65 | 2022-2023 | Aemcolo, Talicia, Movantik |
| Phathom Pharmaceuticals, INC. | $75.63 | 2024 | Voquezna |
| Boston Scientific Corporation | $68.50 | 2025 | Ams 700 |
| Braintree Laboratories, INC. | $52.54 | 2022-2023 | Sutab, Suflave |
| Celgene Corporation | $42.95 | 2022-2023 | Zeposia |
| Vivus LLC | $30.00 | 2023 | Qsymia |
| Lilly USA, LLC | $23.69 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.57 | 2023 | Cyltezo |
| Ipsen Biopharmaceuticals, INC | $23.49 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $21.18 | 2022 | |
| Exact Sciences Corporation | $20.97 | 2023 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $18.89 | 2023 | |
| Merck Sharp & Dohme LLC | $16.42 | 2024 | Dificid |
| Qol Medical, LLC | $15.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidy Dorta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.